biotech investing Lexaria's Human Study GLP-1-H26-7 Reaches Full Enrollment and Continues Dosing on Schedule
biotech investing Lexaria Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
biotech investing Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
biotech investing DehydraTECH-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria's 2026 Animal Study #2
biotech investing DehydraTECH-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria's 2026 Animal Study #2
Centurion to Resume Trading and Provides Update on Option to Acquire the Brothers Gold Project, Suriname
Equity Metals Files Technical Report on Silver Queen Project with Significant Increase in Ag-Au-Zn Mineral Resources
